Unknown

Dataset Information

0

Effector memory differentiation increases detection of replication-competent HIV-l in resting CD4+ T cells from virally suppressed individuals.


ABSTRACT: Studies have demonstrated that intensive ART alone is not capable of eradicating HIV-1, as the virus rebounds within a few weeks upon treatment interruption. Viral rebound may be induced from several cellular subsets; however, the majority of proviral DNA has been found in antigen experienced resting CD4+ T cells. To achieve a cure for HIV-1, eradication strategies depend upon both understanding mechanisms that drive HIV-1 persistence as well as sensitive assays to measure the frequency of infected cells after therapeutic interventions. Assays such as the quantitative viral outgrowth assay (QVOA) measure HIV-1 persistence during ART by ex vivo activation of resting CD4+ T cells to induce latency reversal; however, recent studies have shown that only a fraction of replication-competent viruses are inducible by primary mitogen stimulation. Previous studies have shown a correlation between the acquisition of effector memory phenotype and HIV-1 latency reversal in quiescent CD4+ T cell subsets that harbor the reservoir. Here, we apply our mechanistic understanding that differentiation into effector memory CD4+ T cells more effectively promotes HIV-1 latency reversal to significantly improve proviral measurements in the QVOA, termed differentiation QVOA (dQVOA), which reveals a significantly higher frequency of the inducible HIV-1 replication-competent reservoir in resting CD4+ T cells.

SUBMITTER: Wonderlich ER 

PROVIDER: S-EPMC6812841 | biostudies-literature | 2019 Oct

REPOSITORIES: biostudies-literature

altmetric image

Publications

Effector memory differentiation increases detection of replication-competent HIV-l in resting CD4+ T cells from virally suppressed individuals.

Wonderlich Elizabeth R ER   Subramanian Krupa K   Cox Bryan B   Wiegand Ann A   Lackman-Smith Carol C   Bale Michael J MJ   Stone Mars M   Hoh Rebecca R   Kearney Mary F MF   Maldarelli Frank F   Deeks Steven G SG   Busch Michael P MP   Ptak Roger G RG   Kulpa Deanna A DA  

PLoS pathogens 20191014 10


Studies have demonstrated that intensive ART alone is not capable of eradicating HIV-1, as the virus rebounds within a few weeks upon treatment interruption. Viral rebound may be induced from several cellular subsets; however, the majority of proviral DNA has been found in antigen experienced resting CD4+ T cells. To achieve a cure for HIV-1, eradication strategies depend upon both understanding mechanisms that drive HIV-1 persistence as well as sensitive assays to measure the frequency of infec  ...[more]

Similar Datasets

| S-EPMC3754042 | biostudies-literature
| S-EPMC6276895 | biostudies-other
| S-EPMC4249150 | biostudies-literature
| S-EPMC5505781 | biostudies-literature
| S-EPMC8479831 | biostudies-literature
| S-EPMC6489248 | biostudies-literature
| S-EPMC5807378 | biostudies-literature
| S-EPMC6933087 | biostudies-literature
| S-EPMC7760715 | biostudies-literature
| S-EPMC5338778 | biostudies-literature